Characterization of fibrosis-promoting factors and siRNA-mediated therapies in C-protein-induced experimental autoimmune myocarditis
Keywords: CC2; recombinant cardiac C-protein fragment 2; DCM; dilated cardiomyopathy; EAC; experimental autoimmune carditis; MMP; matrix metalloproteinase; Experimental autoimmune myocarditis; Cardiac fibrosis; C-protein; siRNA-mediated immunotherapy;